Recombinant adeno-associated virus vector design and gene expression in the mammalian brain

This publication has 107 references indexed in Scilit:

• Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes
  Gene Therapy, 2001
• Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons
  Gene Therapy, 2001
• CMV-β-Actin Promoter Directs Higher Expression from an Adeno-Associated Viral Vector in the Liver than the Cytomegalovirus or Elongation Factor 1α Promoter and Results in Therapeutic Levels of Human Factor X in Mice
  Human Gene Therapy, 2001
• Chronic Ethanol Increases Adeno–Associated Viral Transgene Expression in Rat Liver Via Oxidant and NfκB–Dependent Mechanisms
  Hepatology, 2000
• Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield
  Gene Therapy, 1999
• Adeno-Associated Virus-Mediated Gene Transfer to the Brain: Duration and Modulation of Expression
  Human Gene Therapy, 1999
• Selective and Rapid Uptake of Adeno-Associated Virus Type 2 in Brain
  Human Gene Therapy, 1998
• Factors Influencing Recombinant Adeno-Associated Virus Production
  Human Gene Therapy, 1998
• Efficient selection for high-expression transfectants with a novel eukaryotic vector
  Gene, 1991
• MEASUREMENT OF NEURON‐SPECIFIC (NSE) AND NON‐NEURONAL (NNE) ISOENZYMES OF ENOLASE IN RAT, MONKEY AND HUMAN NERVOUS TISSUE
  Journal of Neurochemistry, 1979